Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

News: Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
09/15Calliditas Therapeutics Shares Drop 10% After PDUFA Date Pushed Back
DJ
09/15Abbott Laboratories Declares Quarterly Dividend, Payable on November 15, 2021
CI
09/15Correction to Biogen Plans Phase 3b Trial Article
DJ
09/15BAYER AG : Credit Suisse sticks Neutral
MD
09/15ABIVAX : Nombre d'actions composant le capital social et nombre total de droits de vote au 31.08.21.
DJ
09/15French National Agency for the Safety of Medicines and Health Products Approves NFL Biosciences's Phase II/III Clinical Trial to Assess the Efficacy and Safety of Its NFL-101 Smoking Cessation Treatment
CI
09/15Virbac SA Provides Revenue Guidance for the Year 2021
CI
09/15Australis Capital Inc. Expands California Footprint
CI
09/15Sienna Senior Living Inc. Announces September Dividend, Payable on October 15, 2021
CI
09/15Glenmark Pharmaceuticals Limited Announces Intimation of Buyback in Respect of the Outstanding 2.00% Resettable Onward Starting Equity-Linked Securities Due 2022
CI
09/15AXIM Biotechnologies, Inc. Appoints Jeff Busby as Senior VP Business Development
CI
09/15Ampio Pharmaceuticals, Inc. Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering from Severe Osteoarthritis of the Knee
CI
09/15MODERNA : U.S. hopes COVID vaccine boosters will decrease not just deaths, but virus spread
RE
09/15CohBar, Inc. Appoints Joanne Yun as Director
CI
09/15Chartwell Retirement Residences Announces Cash Distribution, Payable on October 15, 2021
CI
Discover
09/15Ortelius Advisors Solicits Proxies from Shareholders of Capital Senior Living
CI
09/15AbCellera Biologics Inc. Announces Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines
CI
09/15Sharecare, Inc. Announces Executive Appointments
CI
09/15Lineage Cell Therapeutics, Inc. Reports Updated Interim Results from Its Ongoing, 24-Patient Phase 1/2A Clinical Study of Its Lead Product Candidate, Opregen
CI
09/15Allied Corp. Completes the Construction of its 8900 Square Foot Modular Building
CI
09/15Magenta Therapeutics Gets IND Clearance for MGTA-117
DJ
09/15WellteQ Digital Health Inc. Announces SaaS Revenue Guidance for the Year Ended June 30, 2021
CI
09/15SOC Telemed, Inc. Re-Affirms Earnings Guidance for the Year 2021
CI
09/15SOC Telemed, Inc. Announces CFO Changes
CI
09/15Albireo Pharma, Inc. Announces Bylvay® Now Available in Germany
CI
09/15Coherus Biosciences, Inc. and Shanghai Junshi Biosciences Co., Ltd. Announces Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine
CI
09/15Simulations Plus, Inc. Releases Version 10.3 of its Machine Learning Modeling Platform
CI
09/15Predictive Oncology Inc. Announces Board Changes
CI
09/15Unrivaled Brands, Inc. Launches New State of the Art Cultivation Facility
CI
09/15Triple-S Management Corporation Announces Senior Leadership Changes
CI
09/15Ortivus Wins Contract for Defibrillators to Region Jönköping County's Hospital Care
CI
09/15Oramed Pharmaceuticals Inc. Announces Phase 2 Oral Insulin NASH Trial Reaches over 50% Enrollment
CI
09/15Jeevan Scientific Technology Limited Approves Dividend for the Financial Year 2020-21
CI
09/15Stryker Launches New Tendon Fixation Device System
CI
09/15PhaseBio Pharmaceuticals, Inc. Announces Board Changes
CI
09/15Eastern Health Selects Allscripts as One of Its Partners to Further Healthcare Innovation
CI
09/15Eyenovia, Inc. Enters into Amendment to Certain License Agreement with Arctic Vision (Hong Kong) Limited
CI
09/15Inspira Technologies Oxy B.H.N. Ltd. Files a Patent Application for a Supportive Device to be Utilized with the ART Device
CI
09/15Aptorum Group Limited Receives IND Clearance From the US FDA to Initiate Clinical Trials for Repurposed Small Molecule Drug SACT-1 for the Treatment of Neuroblastoma
CI
09/15Magenta Therapeutics, Inc. Announces That Its Investigational New Drug Application for MGTA-117 Is Active with the U.S. Food and Drug Administration
CI
09/15Fate Therapeutics, Inc. Announces Publication of FT538 Preclinical Data Demonstrating Enhanced Serial Killing and Functional Persistence without Cytokine Support
CI
09/15CareDx, Inc Names Art Torres to Board of Directors
CI
09/15Vaccinex, Inc. Presents New and Promising Phase 2 SIGNAL Trial Data in Plenary Session at European Huntington’s Disease Network Meeting
CI
09/15Extendicare Inc. Declares Cash Dividend, Payable on October 15, 2021
CI
09/15NuCana plc Announces Enrollment of Required Number of Patients to Conduct First Interim Analysis in the Phase III Biliary Tract Cancer Study
CI
09/15Jounce Therapeutics, Inc. Announces Board Changes
CI
09/15Saniona Appoints Wendy Dwyer as Chief Business Officer
CI
09/15BioLife Solutions, Inc. Announces Retirement of Roderick De Greef as Chief Financial Officer
CI
09/15Aptorum Group Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2021
CI
09/15Calliditas Therapeutics Has PDUFA Goal Date Extended to Dec. 15
DJ
09/15Exact Sciences in Talks With Pfizer Amid Cologuard Sales-Force Changes
DJ
09/15Magle Chemoswed Enters Long-Term Manufacturing Agreement with Oncopeptides
CI
09/15Adastra Holdings Announces Preliminary Unaudited Sales Results in August 2021
CI
09/15Rapid Dose Therapeutics Corp. and McMaster University Provide COVID-19 Vaccine Research Update Including Significant Achievement of Milestones
CI
09/15Oragenics Initiates COVID-19 Challenge Study Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate
CI
09/15Biogen Inc Announces Plans to Initiate Global Phase 3B Clinical Study, ASCEND
CI
09/15BridgeBio Pharma Receives FDA Fast Track Designation for Investigational Therapy for the Treatment of Limb-girdle Muscular Dystrophy Type 2i
CI
09/15OpGen, Inc Announces Clinical Data from Investigator-Initiated and Driven Prospective Randomized Controlled Multicenter Study
CI
09/15Pacira BioSciences, Inc. Announces Preliminary Product Sales Results for August 2021
CI
09/15REGENERON PHARMACEUTICALS : U.S. buys additional doses of Eli Lilly, Regeneron COVID-19 therapy
RE
09/15Theravance Biopharma, Inc. Announces Management Changes
CI
09/15Veeva Announces New Application to Speed Validation Execution
CI
09/15HOOKIPA Pharma Inc. Announces Clinical Collaboration with Merck & Co., Inc., Kenilworth, NJ., USA to evaluate HB-200 in combination with KEYTRUDA® (pembrolizumab) in patients with advanced head and neck cancers
CI
09/154D pharma Presents Two Clinical Posters for Live Biotherapeutic MRx0518 at the European Society for Medical Oncology Congress 2021
CI
09/15Autolus Therapeutics plc Announces Board Changes
CI
Discover
09/15Actinium Pharmaceuticals, Inc. Completes Enrollment in the Pivotal Phase 3 SIERRA Trial of Iomab-B
CI
09/15BeiGene, Ltd. announces U.S. Food and Drug Administration Grants Brukinsa Approval in Relapsed or Refractory Marginal Zone Lymphoma
CI
09/15TAYSHA GENE THERAPIES ANNOUNCES PUBLICATION OF POSITIVE PRECLINICAL DATA FOR TSHA-104 DEMONSTRATING THERAPEUTIC POTENTIAL IN SURF1-ASSOCIATED LEIGH SYNDROME IN JOURNAL MOLECULAR THERAPY : Methods & Clinical Development
CI
09/15Seres Therapeutics Achieves Enrollment of 300 Subjects with Phase 3 Ecospor IV Open-Label Extension Study of SER-109
CI
09/15Immunovant, Inc. Appoints Renee Barnett as Chief Financial Officer, Effective from October 4, 2021
CI
Prev.1   2  3  4  5  6  7  8  9  10Next